Incorporation of paclitaxel-based hyperthermic intraperitoneal chemotherapy in patients with advanced-stage ovarian cancer treated with neoadjuvant chemotherapy followed by interval debulking surgery: a protocol-based pilot study-Reference-Cited by-同舟云学术

Incorporation of paclitaxel-based hyperthermic intraperitoneal chemotherapy in patients with advanced-stage ovarian cancer treated with neoadjuvant chemotherapy followed by interval debulking surgery: a protocol-based pilot study

Published:2019 Issue:1 Volume:30 Page:
ISSN:2005-0380
Container-title:Journal of Gynecologic Oncology
language:en
Short-container-title:J Gynecol Oncol

Author:

Lee Yong Jae¹^ORCID,Lee Jung-Yun¹^ORCID,Cho Min-Soo²,Nam Eun Ji¹^ORCID,Kim Sang Wun¹^ORCID,Kim Sunghoon¹^ORCID,Kim Young Tae¹^ORCID

Affiliation:

1. Department of Obstetrics and Gynecology, Institute of Women's Life Medical Science, Yonsei University College of Medicine, Seoul, Korea.

2. Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.

Funder

National Research Foundation of Korea

Yonsei University College of Medicine

Shin Poong Pharm. Co., Ltd

Publisher

Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy

Subject

Obstetrics and Gynaecology,Oncology,General Medicine

Link

https://synapse.koreamed.org/pdf/10.3802/jgo.2019.30.e3

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The 2022 PSOGI International Consensus on HIPEC Regimens for Peritoneal Malignancies: HIPEC Technologies;Annals of Surgical Oncology;2024-07-22

2. The impact of Paclitaxel-based hyperthermic intraperitoneal chemotherapy in advanced high-grade serous ovarian cancer patients - interim analysis of safety and immediate efficacy of a randomized control trial (C-HOC trial);Journal of Ovarian Research;2024-07-12

3. Determining the maximum tolerated dose of paclitaxel combined with fixed dose of cisplatin for hyperthermic intraperitoneal chemotherapy in ovarian cancer: A multicenter phase I trial;Gynecologic Oncology;2024-02

4. Secondary cytoreductive surgery with and without hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer;Gland Surgery;2023-12

5. Hyperthermic Intraperitoneal Chemotherapy After Interval Cytoreductive Surgery for Patients With Advanced-Stage Ovarian Cancer Who Had Received Neoadjuvant Chemotherapy;JAMA Surgery;2023-11-01